Ming Ma

682 citations
56 papers · 490 indexed · h-index 13
Topics
Ferroptosis and cancer prognosis (8 papers)Cancer-related molecular mechanisms research (6 papers)Renal cell carcinoma treatment (5 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Ming Ma

51 papers receiving 483 citations

Peers

Ming Ma
Comparison fields: 5 of 74
  • Molecular Biology 289
  • Cancer Research 140
  • Pulmonary and Respiratory Medicine 123
  • Oncology 117
  • Surgery 66
Replace Hang Lv with:
Hang Lv China
Liangyu Bie China
Rohit Upadhyay India
Funan Liu China
Rajalakshmi Nair United States
Qingzhou Guan China
Xiaoqing Jia China
Rocky L.K. Ho Hong Kong
Catia Lippolis Italy
Ming Ma relative to Hang Lv China Hang Lv's profile →
Citations per field
00.5×
Hang Lv · 1×
Citations per year

Countries citing papers authored by Ming Ma

Since Specialization
Citations

This map shows the geographic impact of Ming Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ma more than expected).

Fields of papers citing papers by Ming Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ma. The network helps show where Ming Ma may publish in the future.

Co-authorship network of co-authors of Ming Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Ma. A scholar is included among the top collaborators of Ming Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Ma. Ming Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 1
4 0
5 4
6 1
7 0
8 4
9 4
10 5
11 13
12 17
13 10
14 16
15
Knockdown of FAM83D Enhances Radiosensitivity in Coordination with Irradiation by Inhibiting EMT via the Akt/GSK-3β/Snail Signaling Pathway in Human Esophageal Cancer Cells
2
16 16
17 17
18 9
19 42
20 13

About Ming Ma

Ming Ma is a scholar working on Cancer Research, Gastroenterology and Pathology and Forensic Medicine, having authored 56 papers that have together received 490 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (6 papers) and Renal cell carcinoma treatment (5 papers). The work is most often cited by research in Cancer Research (140 citations), Oncology (117 citations) and Molecular Biology (289 citations). Ming Ma has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Wancai Yang, Yongchen Guo, Yonghua Bao, Wenjie Xie, Binbin Gong, Ting Sun, Liang Wang, Meiyuan Chen, Zhilong Li and Yifu Liu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026